Barclays PLC grew its holdings in TriMas Co. (NASDAQ:TRS - Free Report) by 51.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 104,163 shares of the industrial products company's stock after acquiring an additional 35,371 shares during the quarter. Barclays PLC owned 0.26% of TriMas worth $2,560,000 at the end of the most recent reporting period.
A number of other hedge funds also recently modified their holdings of TRS. Sterling Capital Management LLC increased its stake in TriMas by 815.5% in the 4th quarter. Sterling Capital Management LLC now owns 1,300 shares of the industrial products company's stock valued at $32,000 after buying an additional 1,158 shares during the last quarter. KLP Kapitalforvaltning AS bought a new stake in TriMas during the fourth quarter worth about $202,000. Quantbot Technologies LP boosted its position in TriMas by 203.5% during the fourth quarter. Quantbot Technologies LP now owns 11,978 shares of the industrial products company's stock valued at $295,000 after purchasing an additional 8,031 shares during the last quarter. Wells Fargo & Company MN increased its position in shares of TriMas by 21.1% during the 4th quarter. Wells Fargo & Company MN now owns 37,729 shares of the industrial products company's stock worth $928,000 after purchasing an additional 6,573 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of TriMas by 3.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company's stock worth $982,000 after purchasing an additional 1,227 shares during the last quarter. Institutional investors and hedge funds own 99.42% of the company's stock.
Insider Activity
In other TriMas news, Director Shawn Sedaghat bought 249,597 shares of the firm's stock in a transaction on Friday, March 7th. The shares were purchased at an average price of $23.83 per share, for a total transaction of $5,947,896.51. Following the completion of the transaction, the director now directly owns 346,825 shares in the company, valued at approximately $8,264,839.75. The trade was a 256.71 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Jeffrey A. Fielkow purchased 2,500 shares of TriMas stock in a transaction dated Friday, February 28th. The stock was bought at an average price of $20.78 per share, for a total transaction of $51,950.00. Following the completion of the purchase, the director now owns 11,013 shares in the company, valued at $228,850.14. This represents a 29.37 % increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 929,634 shares of company stock worth $22,278,549. Corporate insiders own 14.20% of the company's stock.
TriMas Stock Performance
TriMas stock traded down $0.04 during mid-day trading on Tuesday, hitting $24.60. 288,611 shares of the company's stock traded hands, compared to its average volume of 320,221. The stock has a market cap of $1.00 billion, a price-to-earnings ratio of 38.44 and a beta of 0.58. The firm has a 50 day simple moving average of $22.61 and a two-hundred day simple moving average of $24.23. TriMas Co. has a fifty-two week low of $19.33 and a fifty-two week high of $28.51. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44.
TriMas (NASDAQ:TRS - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.03. The firm had revenue of $241.67 million during the quarter, compared to the consensus estimate of $235.41 million. TriMas had a net margin of 2.93% and a return on equity of 9.21%. The business's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period last year, the business posted $0.37 earnings per share. On average, research analysts expect that TriMas Co. will post 1.69 EPS for the current fiscal year.
TriMas Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 13th. Shareholders of record on Tuesday, May 6th will be given a dividend of $0.04 per share. The ex-dividend date of this dividend is Tuesday, May 6th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.65%. TriMas's payout ratio is presently 20.78%.
Wall Street Analysts Forecast Growth
Separately, BWS Financial restated a "buy" rating and set a $40.00 target price on shares of TriMas in a report on Wednesday, April 30th.
View Our Latest Stock Analysis on TriMas
TriMas Profile
(
Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Stories

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report